Isatuximab

IKEMA: isatuximab addition to Kd improves depth of response in myeloma 2:34
IKEMA: isatuximab addition to Kd improves depth of response in myeloma
Thomas Martin • 9 Mar 2021
HRQoL and frail patients with R/R multiple myeloma 2:43
HRQoL and frail patients with R/R multiple myeloma
Maria-Victoria Mateos • 10 Mar 2021
Monoclonal antibodies for myeloma relapsed after ASCT 4:24
Monoclonal antibodies for myeloma relapsed after ASCT
Mohamad Mohty • 24 Feb 2021
Monoclonal antibodies for lenalidomide-refractory multiple myeloma 1:35
Monoclonal antibodies for lenalidomide-refractory multiple myeloma
Enrique Ocio • 19 Feb 2021
Mass spectrometry and response monitoring in multiple myeloma 4:22
Mass spectrometry and response monitoring in multiple myeloma
David Murray • 23 Feb 2021
IKEMA subgroup analysis: Isa + Kd in patients who previously underwent transplantation 3:51
IKEMA subgroup analysis: Isa + Kd in patients who previously underwent transplantation
Thomas Martin • 10 Feb 2021
What does the future of amyloidosis treatment look like? 2:09
What does the future of amyloidosis treatment look like?
Efstathios Kastritis • 11 Dec 2020
SWOG S1702: isatuximab for AL amyloidosis 1:44
SWOG S1702: isatuximab for AL amyloidosis
Vaishali Sanchorawala • 7 Dec 2020
IKEMA: isatuximab + Kd improves response and PFS in R/R myeloma 2:40
IKEMA: isatuximab + Kd improves response and PFS in R/R myeloma
Thomas Martin • 17 Dec 2020
MRD-negativity rates in the IKEMA trial of isa plus kD in R/R myeloma 2:32
MRD-negativity rates in the IKEMA trial of isa plus kD in R/R myeloma
Philippe Moreau • 4 Dec 2020
IKEMA update: isatuximab and kD in R/R myeloma 2:39
IKEMA update: isatuximab and kD in R/R myeloma
Philippe Moreau • 4 Dec 2020
Addressing unmet needs in the treatment of amyloidosis 8:11
Addressing unmet needs in the treatment of amyloidosis
Morie Gertz • 30 Nov 2020
Evolving understanding of multiple myeloma 7:47
Evolving understanding of multiple myeloma
Claudio Cerchione • 6 Sep 2020
Extramedullary disease in myeloma: updates from ASH 2020 3:49
Extramedullary disease in myeloma: updates from ASH 2020
Meral Beksac • 9 Dec 2020
Fixed-volume isatuximab infusion in newly-diagnosed myeloma 2:09
Fixed-volume isatuximab infusion in newly-diagnosed myeloma
Enrique Ocio • 25 Nov 2020
A Phase Ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma 3:28
A Phase Ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma
Enrique Ocio • 25 Nov 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals